SEC Form 4 · accession 0001179110-15-011335
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael John Tomsicek
Officer — Vice President, CFO
Period of report
Jul 15, 2015
Accepted (ET)
Jul 20, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Jul 15, 2015 | A | 25,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2,F3 | $67.55 | Jul 15, 2015 | A | 25,000 | A | Jul 15, 2016 | Jul 15, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of July 15, 2016, July 15, 2017 and July 15, 2018, so long as the reporting person continues to be employed by the issuer on the vesting dates.
- F2Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- F3These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.